| Date | Time | Source | Headline | Symbol | Company |
| 01/09/2012 | 5:05PM | PR Newswire (US) | Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/03/2012 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/07/2011 | 4:07PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/23/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/15/2011 | 4:10AM | Zacks | Company News for November 15, 2011 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/11/2011 | 9:00AM | Marketwired | Europe Situation Forecasts Change -- Report Highlights Amylin Pharmaceuticals, Inc. and priceline.com Incorporated | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2011 | 8:00AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthca... | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2011 | 7:28AM | Zacks | Amylin, Lilly Part Ways - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/09/2011 | 4:10AM | Zacks | Company News for November 9, 2011 - Corporate Summary | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/08/2011 | 6:41AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/08/2011 | 6:30AM | PR Newswire (US) | Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2011 | 8:16AM | Marketwired | Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/28/2011 | 4:49PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/21/2011 | 10:08AM | Zacks | Amylin Posts Lower Loss - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/20/2011 | 6:02AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 6:10PM | PR Newswire (US) | BYETTA® Approved for Use with Insulin Glargine in the U.S. | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 4:17PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/19/2011 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/18/2011 | 4:39AM | Dow Jones News | UK Body Recommends Lilly, Amylin Diabetes Drug Bydureon | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/14/2011 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/12/2011 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/11/2011 | 10:45AM | Zacks | Alkermes Upped to Outperform - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/06/2011 | 5:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/22/2011 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/15/2011 | 1:20PM | Dow Jones News | Icahn Firm's Denner Might Leave To Start Hedge Fund -Bloomberg | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/15/2011 | 5:45AM | Zacks | Novo Nordisk's Data at EASD - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/13/2011 | 11:00AM | Zacks | Data Announced on Bydureon - Analyst Blog | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |